195 related articles for article (PubMed ID: 12553496)
1. Increased DNA adducts in Barrett's esophagus and reflux-related esophageal malignancies.
Salminen JT; Rämö OJ; Ahotupa MO; Färkkilä MA; Salo JA
Ann Med; 2002; 34(7-8):565-70. PubMed ID: 12553496
[TBL] [Abstract][Full Text] [Related]
2. Familiality in Barrett's esophagus, adenocarcinoma of the esophagus, and adenocarcinoma of the gastroesophageal junction.
Chak A; Ochs-Balcom H; Falk G; Grady WM; Kinnard M; Willis JE; Elston R; Eng C
Cancer Epidemiol Biomarkers Prev; 2006 Sep; 15(9):1668-73. PubMed ID: 16985029
[TBL] [Abstract][Full Text] [Related]
3. Risk factors, DNA damage, and disease progression in Barrett's esophagus.
Olliver JR; Hardie LJ; Gong Y; Dexter S; Chalmers D; Harris KM; Wild CP
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):620-5. PubMed ID: 15767340
[TBL] [Abstract][Full Text] [Related]
4. A newly identified susceptibility locus near FOXP1 modifies the association of gastroesophageal reflux with Barrett's esophagus.
Dai JY; de Dieu Tapsoba J; Buas MF; Onstad LE; Levine DM; Risch HA; Chow WH; Bernstein L; Ye W; Lagergren J; Bird NC; Corley DA; Shaheen NJ; Wu AH; Reid BJ; Hardie LJ; Whiteman DC; Vaughan TL
Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1739-47. PubMed ID: 26377193
[TBL] [Abstract][Full Text] [Related]
5. Barrett's esophagus and adenocarcinoma of the esophagus and gastroesophageal junction.
Duhaylongsod FG; Wolfe WG
J Thorac Cardiovasc Surg; 1991 Jul; 102(1):36-41; discussion 41-2. PubMed ID: 2072727
[TBL] [Abstract][Full Text] [Related]
6. No association between hOGG1, XRCC1, and XPD polymorphisms and risk of reflux esophagitis, Barrett's esophagus, or esophageal adenocarcinoma: results from the factors influencing the Barrett's adenocarcinoma relationship case-control study.
Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):736-9. PubMed ID: 18349297
[TBL] [Abstract][Full Text] [Related]
7. Oxidative stress has a role in malignant transformation in Barrett's oesophagus.
Sihvo EI; Salminen JT; Rantanen TK; Rämö OJ; Ahotupa M; Färkkilä M; Auvinen MI; Salo JA
Int J Cancer; 2002 Dec; 102(6):551-5. PubMed ID: 12447994
[TBL] [Abstract][Full Text] [Related]
8. Barrett's esophagus: an acquired condition with genetic predisposition.
Fahmy N; King JF
Am J Gastroenterol; 1993 Aug; 88(8):1262-5. PubMed ID: 8338095
[TBL] [Abstract][Full Text] [Related]
9. High risk of malignancy in familial Barrett's esophagus: presentation of one family.
Munitiz V; Parrilla P; Ortiz A; Martinez-de-Haro LF; Yelamos J; Molina J
J Clin Gastroenterol; 2008 Aug; 42(7):806-9. PubMed ID: 18385604
[TBL] [Abstract][Full Text] [Related]
10. [Adenocarcinoma of the esophagogastric junction: association with Barrett esophagus and gastroesophageal reflux--surgical results in 122 patients].
Schumpelick V; Dreuw B; Ophoff K; Fass J
Leber Magen Darm; 1996 Mar; 26(2):75-6, 79-80, 83-6. PubMed ID: 8684248
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase-2 and inducible nitric oxide synthase gene polymorphisms and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.
Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):727-31. PubMed ID: 18349295
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA profile in neosquamous esophageal mucosa following ablation of Barrett's esophagus.
Sreedharan L; Mayne GC; Watson DI; Bright T; Lord RV; Ansar A; Wang T; Kist J; Astill DS; Hussey DJ
World J Gastroenterol; 2017 Aug; 23(30):5508-5518. PubMed ID: 28852310
[TBL] [Abstract][Full Text] [Related]
13. Familial aggregation of gastroesophageal reflux in patients with Barrett's esophagus and esophageal adenocarcinoma.
Romero Y; Cameron AJ; Locke GR; Schaid DJ; Slezak JM; Branch CD; Melton LJ
Gastroenterology; 1997 Nov; 113(5):1449-56. PubMed ID: 9352846
[TBL] [Abstract][Full Text] [Related]
14. Barrett's esophagus and risk of esophageal adenocarcinoma.
Cossentino MJ; Wong RK
Semin Gastrointest Dis; 2003 Jul; 14(3):128-35. PubMed ID: 14653412
[TBL] [Abstract][Full Text] [Related]
15. [Expression of transcription factor in Barrett's esophagus].
Mutoh H
Nihon Rinsho; 2005 Aug; 63(8):1367-71. PubMed ID: 16101223
[TBL] [Abstract][Full Text] [Related]
16. Determination of risk for Barrett's esophagus and esophageal adenocarcinoma.
Thrift AP
Curr Opin Gastroenterol; 2016 Jul; 32(4):319-24. PubMed ID: 27276368
[TBL] [Abstract][Full Text] [Related]
17. The molecular signature of normal squamous esophageal epithelium identifies the presence of a field effect and can discriminate between patients with Barrett's esophagus and patients with Barrett's-associated adenocarcinoma.
Brabender J; Marjoram P; Lord RV; Metzger R; Salonga D; Vallböhmer D; Schäfer H; Danenberg KD; Danenberg PV; Selaru FM; Baldus SE; Hölscher AH; Meltzer SJ; Schneider PM
Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2113-7. PubMed ID: 16172218
[TBL] [Abstract][Full Text] [Related]
18. Familial aggregation of Barrett's oesophagus, oesophageal adenocarcinoma, and oesophagogastric junctional adenocarcinoma in Caucasian adults.
Chak A; Lee T; Kinnard MF; Brock W; Faulx A; Willis J; Cooper GS; Sivak MV; Goddard KA
Gut; 2002 Sep; 51(3):323-8. PubMed ID: 12171951
[TBL] [Abstract][Full Text] [Related]
19. Reflux control is important in the management of Barrett's Esophagus: results from a retrospective 1,830 patient cohort.
Brown CS; Lapin B; Wang C; Goldstein JL; Linn JG; Denham W; Haggerty SP; Talamonti MS; Howington JA; Carbray J; Ujiki MB
Surg Endosc; 2015 Dec; 29(12):3528-34. PubMed ID: 25676204
[TBL] [Abstract][Full Text] [Related]
20. Adenocarcinoma of the esophagogastric junction and Barrett's esophagus.
Cameron AJ; Lomboy CT; Pera M; Carpenter HA
Gastroenterology; 1995 Nov; 109(5):1541-6. PubMed ID: 7557137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
